Acadia Pharmaceuticals | ACAD - Passifs Courants

Prix De L'Action
21.85
Variation Quotidienne
-0.60 -2.67%
Mensuellement
-1.58%
Annuel
46.55%
Q2 Prévisions
21.49




Passifs Courants Changement Date
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Cara Therapeutics USD 11.04M 362K 2025-09
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Cytokinetics USD 202.45M 60.31M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Incyte USD 1.49B 25.52M 2026-03
J&J USD 57.72B 3.59B 2026-03
Moderna USD 2.4B 408M 2026-03
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Prothena USD 40.84M 10.59M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12